Related references
Note: Only part of the references are listed.Experimental approaches for the treatment of malignant gliomas
Leopold Arko et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma
Balazs Hegedus et al.
CANCER RESEARCH (2008)
TORC1 is essential for NF1-associated malignancies
Cory M. Johannessen et al.
CURRENT BIOLOGY (2008)
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
Jaclyn LoPiccolo et al.
DRUG RESISTANCE UPDATES (2008)
Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors
Gunnar Johansson et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Novel dual-reporter preclinical screen for antiastrocytoma agents identifies cytostatic and cytotoxic compounds
Jessica J. Hawes et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
A dual phosphoinositide-3-kinase α/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma
Qi-Wen Fan et al.
CANCER RESEARCH (2007)
The power of riboswitches
Jeffrey E. Barrick et al.
SCIENTIFIC AMERICAN (2007)
Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: Correlation with EGFR status, tumor grade, and survival
Masahiro Mizoguchi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
HIV protease inhibitors decrease VEGF/HIF-1α expression and angiogenesis in glioblastoma cells
Nabendu Pore et al.
NEOPLASIA (2006)
Nelfinavir down-regulates hypoxia-inducible factor 1α and VEGF expression and increases tumor oxygenation:: Implications for radiotherapy
Nabendu Pore et al.
CANCER RESEARCH (2006)
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08
Patrick Y. Wen et al.
CLINICAL CANCER RESEARCH (2006)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan et al.
CANCER CELL (2006)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo
AK Gupta et al.
CANCER RESEARCH (2005)
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib
DA Haas-Kogan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors
B Dasgupta et al.
CANCER RESEARCH (2005)
PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas
JW Lee et al.
ONCOGENE (2005)
Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects
KM Reilly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A clone-array pooled shotgun strategy for sequencing large genomes
WW Cai et al.
GENOME RESEARCH (2001)
Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
KM Reilly et al.
NATURE GENETICS (2000)
Share Paper
